Results 101 to 110 of about 5,084 (185)

CpG-ODN-induced sustained expression of BTLA mediating selective inhibition of human B cells [PDF]

open access: yes, 2018
BTLA (B- and T-lymphocyte attenuator) is a prominent co-receptor that is structurally and functionally related to CTLA-4 and PD-1. In T cells, BTLA inhibits TCR-mediated activation.
Gertner-Dardenne, Julie   +7 more
core  

Defective BTLA functionality is rescued by restoring lipid metabolism in lupus CD4+ T cells

open access: yes, 2018
International audienceCoinhibitory receptors play an important role in the prevention of autoimmune diseases, such as systemic lupus erythematosus (SLE), by limiting T cell activation.
Sagez, Flora   +6 more
core   +1 more source

B- and T-Lymphocyte Attenuator Targeting Protects Against the Acute Phase of Graft Versus Host Reaction by Inhibiting Donor Anti-Host Cytotoxicity

open access: yes
[EN] Background. B-and T-lymphocyte attenuator (BTLA) functions as a coinhibitory/costimulatory molecule that belongs to the immunoglobulin superfamily and exhibits a pattern of expression restricted to the hematopoietic compartment.
Pérez Martínez, Claudia   +5 more
core   +1 more source

Altered BTLA expression and function in lymphocytes during lupus: consequences for therapeutic targeting

open access: yes, 2023
International audienceB and T lymphocyte attenuator (BTLA) is a co-inhibitory receptor expressed by lymphoid cells that negatively regulates the immune response.
Gherardi, Léa   +2 more
core   +1 more source

Poster Sessions

open access: yes
HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Publication Only

open access: yes
HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

PD-1 et BTLA au coeur des lymphocytes B : du physiologique aux lymphomes

open access: yes, 2011
La réponse immunitaires est régulée par des molécules de co-signalisation, qui, en apportant des signaux inhibiteurs ou activateurs, modulent les fonctions lymphocytaires.
Thibult, Marie-Laure
core  

Stimulation of the Co-inhibitory BTLA Pathway Protects Against Atherosclerosis by Selectively Reducing Atherogenic B Cells

open access: yes, 2018
B-and T-lymphocyte attenuator (BTLA) is a co-inhibitory molecule which was identified as a marker for Th1 cells. However, nowadays it is known that BTLA is most abundantly expressed on B cells. Also, we showed earlier that BTLA was specifically expressed
Schaftenaar, F.H.   +11 more
core   +1 more source

Mutant HVEM in lymphoma disrupts BTLA and CD160 regulation of anti-tumor signaling

open access: yesFrontiers in Immunology
IntroductionSomatic mutations can rewire tumor–immune interactions to favor cancer progression. Here, we define the functional impact of missense mutations in Herpesvirus entry mediator (HVEM, TNFRSF14), a receptor frequently altered in lymphoma and ...
Wai Wai Lin   +8 more
doaj   +1 more source

B and T Lymphocyte Attenuator Regulates B Cell Receptor Signaling by Targeting Syk and BLNK

open access: yesJournal of Immunology, 2009
Andrew C. Vendel   +5 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy